Infantile Spasms Therapeutics market

Infantile Spasms Therapeutics Market, Global Outlook and Forecast 2023-2029

  • 16 March 2023
  • Life Sciences
  • 64 Pages
  • Report code : PMR-7603866

  • 4.7 (158)

Infantile Spasms Therapeutics Market

Download FREE Report Sample

  Download Free sample

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

Infantile Spasms Therapeutics Market aims to provide a comprehensive presentation of the global market for Infantile Spasms Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infantile Spasms Therapeutics. Infantile Spasms Therapeutics Market contains market size and forecasts of Infantile Spasms Therapeutics in global, including the following market information:

Global Infantile Spasms Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

The global Infantile Spasms Therapeutics market was valued at US$ 146.1 million in 2022 and is projected to reach US$ 185.2 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.

In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

We surveyed the Infantile Spasms Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Infantile Spasms Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Infantile Spasms Therapeutics Market Segment Percentages, by Type, 2022 (%)

Oral

Injection

Global Infantile Spasms Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Infantile Spasms Therapeutics Market Segment Percentages, by Application, 2022 (%)

Hospital

Clinic

Other

Global Infantile Spasms Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Infantile Spasms Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Infantile Spasms Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies Infantile Spasms Therapeutics revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Mallinckrodt

H. Lundbeck

Insys Therapeutics

Orphelia Pharma

Valerion Therapeutics

Catalyst Pharmaceuticals

Anavex Life Sciences

Retrophin

GW Pharmaceuticals

Outline of Major Chapters:

Chapter 1: Introduces the definition of Infantile Spasms Therapeutics, market overview.

Chapter 2: Global Infantile Spasms Therapeutics market size in revenue.

Chapter 3: Detailed analysis of Infantile Spasms Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Infantile Spasms Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Infantile Spasms Therapeutics Market

Leave This Empty: